Palmer Pamela P 4
4 · ACELRX PHARMACEUTICALS INC · Filed Aug 25, 2023
Insider Transaction Report
Form 4
Palmer Pamela P
Chief Medical Officer
Transactions
- Sale
Common Stock
[F1][F2]2023-08-24$1.17/sh−9,514$11,131→ 38,195 total - Sale
Common Stock
[F2]2023-08-25$1.09/sh−7,442$8,104→ 30,753 total
Footnotes (2)
- [F1]The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.17 to $1.19 on August 24, 2023. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares sold at each separate price.
- [F2]Balance includes non-reportable acquisition of 4,394 shares of Common Stock through the Company's Employee Stock Purchase Plan on February 28, 2023.
Signature
/s/ Martha Adler. Attorney-In-Fact|2023-08-25